The Human Ageing Genomic Resources are at risk. Please support our work at JustGiving.

DrugAge entry for Shatavarin IV

Name
Shatavarin IV 
Synonyms
113982-32-4 • 84633-34-1 • AC1L9BVK • Asparanin B • Asparanin B, >=90% (LC/MS-ELSD) • beta-D-Glucopyranoside, (3beta,5beta,25S)-spirostan-3-ylO-6-deoxy-alpha-L-mannopyranosyl-(1->4)-O-(beta-D-glucopyranosyl-(1->2))- • C08912 • CHEBI:9039 • Sarsasapogenin 3-O-4G-rhamnosylsophoroside • Shatavarin IV • UNII-Z905922Y1P • Z905922Y1P • ZINC253529486 
CAS Number
84633-34-1 
IUPAC Name
 
PubChem CID
 

Summary

Species No. Entries MAX(Avg/Med Lifespan Change %) MEAN(Avg/Med Lifespan Change %) MAX(Max Lifespan Change %) MEAN(Max Lifespan Change %)

Results

Compound/Formulation Species Sex Strain Dosage Avg/Med Lifespan Change (%) Avg/Med Lifespan Significance Max Lifespan Change (%) Reference

Lifespan Charts for Shatavarin IV


References

Smita SS, et al. (2017) Shatavarin IV elicits lifespan extension and alleviates Parkinsonism in Caenorhabditis elegans Free radical research () PubMed

DGIdb Human Drug-Gene Interactions for Shatavarin IV

Interaction Types Gene Symbol Common Name HGNC Id DGIdb Sources References

Stitch DB Human Drug-Protein Interactions for Shatavarin IV

Up to 20 direct protein and drug interactions are displayed, having a medium confidence score (0.450) or above. Second order interactions are tabulated below.

Ensembl Id StringDB Id